Dataset from An Open Label, Two Stage, Phase II Study to Evaluate the Efficacy and Tolerability of ZD6474 in Patients With Locally Advanced or Metastatic Hereditary Medullary Thyroid Carcinoma.
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://doi.org/10.25934/PR00007702
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this open label, two stage, phase II study is to evaluate the efficacy and
tolerability of ZD6474 in patients with locally advanced or metastatic hereditary medullary
thyroid carcinoma.
创建时间：
2024-11-26
